Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Breast Regimens

Metastatic Regimens

Published Sort regimens by
BR Advanced/Metastatic - abemaciclib Id: 392981000210109 Published date: Version: 1.0.0
392981000210109
1.0.0
24/07/2024
BR Metastatic - Abraxane [PACLItaxel nanoparticle albumin bound] [Q1W 2/3] Id: 59791000210109 Published date: Version: 1.0.0
59791000210109
1.0.0
01/09/2022
BR Metastatic - Abraxane [PACLItaxel nanoparticle albumin bound] [Q1W 3/4] Id: 59831000210103 Published date: Version: 1.0.0
59831000210103
1.0.0
01/09/2022
BR Metastatic - Abraxane [PACLItaxel nanoparticle albumin bound] and aTEZOLIzumab Id: 58481000210105 Published date: Version: 2.0.0
58481000210105
2.0.0
22/04/2022
BR Metastatic - AC [DOXOrubicin and CYCLOPHOSPHamide] Id: 59131000210109 Published date: Version: 2.0.0
59131000210109
2.0.0
24/08/2026
BR Metastatic - alpelisib and fulvestrant Id: 506891000210102 Published date: Version: 1.0.0
506891000210102
1.0.0
12/05/2026
BR Metastatic - capecitabine 1000 Id: 52581000210108 Published date: Version: 1.0.0
52581000210108
1.0.0
29/06/2021
BR Metastatic - capecitabine 1000 and trastuzumab Q3W Id: 59191000210105 Published date: Version: 1.0.0
59191000210105
1.0.0
22/04/2022
BR Metastatic - capecitabine 1000, trastuzumab and tucatinib Id: 393191000210100 Published date: Version: 1.0.0
393191000210100
1.0.0
16/08/2024
BR Metastatic - capecitabine 1250 Id: 58671000210105 Published date: Version: 1.0.0
58671000210105
1.0.0
16/11/2021
BR Metastatic - capecitabine 1500 [flat dosing] [7-days on 7-days off] Id: 392961000210101 Published date: Version: 1.0.0
392961000210101
1.0.0
24/07/2024
BR Metastatic - capecitabine 750 and neratinib Id: 392971000210107 Published date: Version: 1.0.0
392971000210107
1.0.0
24/07/2024
BR Metastatic - cARBOplatin Id: 57791000210102 Published date: Version: 2.0.0
57791000210102
2.0.0
22/04/2022
BR Metastatic - cARBOplatin [2 AUC] and gemcitabine Id: 392611000210105 Published date: Version: 1.0.0
392611000210105
1.0.0
29/05/2024
BR Metastatic - cARBOplatin [5 AUC] and gemcitabine Id: 58601000210103 Published date: Version: 3.0.0
58601000210103
3.0.0
30/05/2024
BR Metastatic - cARBOplatin [2 AUC], gemcitabine and pembrolizumab Id: 506881000210104 Published date: Version: 1.0.0
506881000210104
1.0.0
12/05/2026
BR Metastatic - CMF classical [CYCLOPHOSPHamide, metHOTREXATe and fluorouracil] Id: 59811000210105 Published date: Version: 1.0.0
59811000210105
1.0.0
18/09/2023
BR Metastatic - CMF classical IV [CYCLOPHOSPHamide, metHOTREXATe and fluorouracil] Id: 59301000210102 Published date: Version: 1.0.0
59301000210102
1.0.0
18/09/2023
BR Metastatic - CYCLOPHOSPHamide and metHOTREXATe [low dose oral] Id: 58881000210108 Published date: Version: 3.0.0
58881000210108
3.0.0
17/08/2023
BR Metastatic - denosumab Id: 58531000210107 Published date: Version: 1.0.0
58531000210107
1.0.0
22/10/2021
BR Metastatic - DOCEtaxel and pERTUZumab/trastuzumab subcutaneous [Phesgo] Id: 506871000210101 Published date: Version: 1.0.0
506871000210101
1.0.0
12/05/2026
BR Metastatic - DOCEtaxel and trastuzumab Q3W Id: 59151000210103 Published date: Version: 1.0.0
59151000210103
1.0.0
22/04/2022
BR Metastatic - DOCEtaxel, pERTUZumab and trastuzumab Id: 59171000210106 Published date: Version: 1.0.0
59171000210106
1.0.0
22/04/2022
BR Metastatic - DOCEtaxel Q3W Id: 59181000210108 Published date: Version: 1.0.0
59181000210108
1.0.0
22/04/2022
BR Metastatic - DOXOrubicin Q1W Id: 58611000210101 Published date: Version: 1.0.0
58611000210101
1.0.0
18/09/2023
BR Metastatic - DOXOrubicin Q3W Id: 58641000210100 Published date: Version: 1.0.0
58641000210100
1.0.0
22/10/2021
BR Metastatic - EC [epirubicin and CYCLOPHOSPHamide] Id: 57781000210104 Published date: Version: 2.0.0
57781000210104
2.0.0
24/08/2026
BR Metastatic - eribulin Id: 58631000210108 Published date: Version: 1.0.0
58631000210108
1.0.0
22/10/2021
BR Metastatic - everolimus and exemestane Id: 58491000210107 Published date: Version: 1.0.0
58491000210107
1.0.0
22/10/2021
BR Metastatic - fulvestrant Id: 58541000210104 Published date: Version: 1.0.0
58541000210104
1.0.0
22/10/2021
BR Metastatic - gemcitabine Id: 58591000210108 Published date: Version: 1.0.0
58591000210108
1.0.0
22/10/2021
BR Metastatic - goserelin Q12W Id: 58561000210103 Published date: Version: 1.0.0
58561000210103
1.0.0
22/10/2021
BR Metastatic - goserelin Q4W Id: 57801000210103 Published date: Version: 1.0.0
57801000210103
1.0.0
22/10/2021
BR Metastatic - Kadcyla [trastuzumab emtansine] Id: 58511000210100 Published date: Version: 1.0.0
58511000210100
1.0.0
22/10/2021
BR Metastatic - MMM [mitomycin, mitoxantrone and metHOTREXATe] Id: 58521000210105 Published date: Version: 2.0.0
58521000210105
2.0.0
22/04/2022
BR Metastatic - olaparib Id: 264201000210108 Published date: Version: 1.0.0
264201000210108
1.0.0
19/04/2023
BR Metastatic - PACLItaxel nanoparticle albumin bound [Abraxane] [Q1W 2/3] and pembrolizumab Q3W Id: 506861000210107 Published date: Version: 1.0.0
506861000210107
1.0.0
12/05/2026
BR Metastatic - PACLItaxel Q1W Id: 58501000210102 Published date: Version: 2.0.0
58501000210102
2.0.0
22/04/2022
BR Metastatic - PACLItaxel Q1W and pembrolizumab Q3W Id: 506851000210109 Published date: Version: 1.0.0
506851000210109
1.0.0
12/05/2026
BR Metastatic - PACLItaxel Q1W and pERTUZumab/trastuzumab subcutaneous Q3W [Phesgo] Id: 506841000210106 Published date: Version: 1.0.0
506841000210106
1.0.0
12/05/2026
BR Metastatic - PACLItaxel Q1W and trastuzumab Q3W Id: 58581000210106 Published date: Version: 1.0.0
58581000210106
1.0.0
22/10/2021
BR Metastatic - PACLItaxel Q1W, pERTUZumab and trastuzumab Q3W Id: 58621000210106 Published date: Version: 1.0.0
58621000210106
1.0.0
22/10/2021
BR Metastatic - palbociclib Id: 57811000210101 Published date: Version: 1.0.0
57811000210101
1.0.0
22/10/2021
BR Metastatic - pamidronate Id: 58571000210109 Published date: Version: 1.0.0
58571000210109
1.0.0
22/10/2021
BR Metastatic - pembrolizumab Q3W [flat dosing] Id: 58551000210101 Published date: Version: 1.0.0
58551000210101
1.0.0
22/10/2021
BR Metastatic - ribociclib Id: 392601000210108 Published date: Version: 1.0.0
392601000210108
1.0.0
29/05/2024
BR Metastatic - sacituzumab govitecan Id: 393181000210102 Published date: Version: 2.0.0
393181000210102
2.0.0
08/05/2026
BR Metastatic - trastuzumab deruxtecan [Enhertu] Id: 393401000210104 Published date: Version: 2.0.0
393401000210104
2.0.0
12/05/2026
BR Metastatic - trastuzumab Q3W Id: 58651000210102 Published date: Version: 1.0.0
58651000210102
1.0.0
22/10/2021
BR Metastatic - trastuzumab Q3W and vinORELBine [IV] Id: 58461000210102 Published date: Version: 1.0.0
58461000210102
1.0.0
22/10/2021
BR Metastatic - trastuzumab Q3W and vinORELBine [oral] Id: 58471000210108 Published date: Version: 1.0.0
58471000210108
1.0.0
18/09/2023
BR Metastatic - trastuzumab subcutaneous Id: 57831000210108 Published date: Version: 1.0.0
57831000210108
1.0.0
22/10/2021
BR Metastatic - vinORELBine [IV] Id: 57821000210106 Published date: Version: 1.0.0
57821000210106
1.0.0
22/10/2021
BR Metastatic - vinORELBine [oral] Id: 59781000210107 Published date: Version: 1.0.0
59781000210107
1.0.0
01/09/2022
BR Metastatic - vinORELBine [IV], pERTUZumab and trastuzumab Q3W Id: 59801000210108 Published date: Version: 1.0.0
59801000210108
1.0.0
01/09/2022
BR Metastatic - vinORELBine [oral], pERTUZumab and trastuzumab Q3W Id: 393411000210102 Published date: Version: 1.0.0
393411000210102
1.0.0
26/08/2024
BR Metastatic - vinORELBine [IV] Q1W Id: 57771000210101 Published date: Version: 1.0.0
57771000210101
1.0.0
22/10/2021
BR Metastatic - zoledronic acid Q12W Id: 58841000210101 Published date: Version: 1.0.0
58841000210101
1.0.0
16/11/2021
BR Metastatic - zoledronic acid Q4W Id: 58701000210109 Published date: Version: 1.0.0
58701000210109
1.0.0
16/11/2021
Discontinued Regimens Sort regimens by
BR Metastatic - Abraxane [PACLItaxel nanoparticle albumin bound] Q3W Id: 58771000210102 Published date: Version: 1.1.4
58771000210102
1.1.4
20/08/2025

NON-metastatic Regimens

Published Sort regimens by
BR Adjuvant - abemaciclib Id: 393011000210107 Published date: Version: 1.0.0
393011000210107
1.0.0
24/07/2024
BR Adjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] dose dense followed by PACLItaxel dose dense Id: 58861000210100 Published date: Version: 4.0.0
58861000210100
4.0.0
24/08/2026
BR Adjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W followed by PACLItaxel Q1W and trastuzumab Q3W Id: 58681000210107 Published date: Version: 4.0.0
58681000210107
4.0.0
24/08/2026
BR Adjuvant - AC-TH [DOXOrubicin and CYCLOPHOSPHamide] Q3W followed by [DOCEtaxel and trastuzumab] Q3W Id: 59121000210107 Published date: Version: 4.0.0
59121000210107
4.0.0
24/08/2026
BR Adjuvant - capecitabine Id: 58851000210103 Published date: Version: 2.0.0
58851000210103
2.0.0
06/08/2024
BR Adjuvant - capecitabine [metronomic] Id: 393001000210105 Published date: Version: 1.0.0
393001000210105
1.0.0
24/07/2024
BR Adjuvant - CMF classical [CYCLOPHOSPHamide, metHOTREXATe and fluorouracil] Id: 58871000210106 Published date: Version: 3.0.0
58871000210106
3.0.0
06/08/2024
BR Adjuvant - CMF classical IV [CYCLOPHOSPHamide, metHOTREXATe and fluorouracil] Id: 59311000210100 Published date: Version: 3.0.0
59311000210100
3.0.0
06/08/2024
BR Adjuvant - EC [epirubicin and CYCLOPHOSPHamide] Id: 264161000210101 Published date: Version: 3.0.0
264161000210101
3.0.0
24/08/2026
BR Adjuvant - EC-D [epirubicin and CYCLOPHOSPHamide followed by DOCEtaxel] Id: 264211000210105 Published date: Version: 3.0.0
264211000210105
3.0.0
24/08/2026
BR Adjuvant - exemestane and goserelin Id: 58801000210104 Published date: Version: 2.0.0
58801000210104
2.0.0
06/08/2024
BR Adjuvant - Kadcyla [trastuzumab emtansine] Id: 58721000210101 Published date: Version: 2.0.0
58721000210101
2.0.0
06/08/2024
BR Adjuvant - neratinib Id: 58751000210105 Published date: Version: 1.0.0
58751000210105
1.0.0
06/08/2024
BR Adjuvant - olaparib Id: 392991000210106 Published date: Version: 1.0.0
392991000210106
1.0.0
24/07/2024
BR Adjuvant - PACLItaxel Q1W and trastuzumab Q3W Id: 58791000210103 Published date: Version: 3.0.0
58791000210103
3.0.0
06/08/2024
BR Adjuvant - ribociclib Id: 506921000210109 Published date: Version: 1.0.0
506921000210109
1.0.0
12/05/2026
BR Adjuvant - TAMoxifen Id: 506911000210104 Published date: Version: 1.0.0
506911000210104
1.0.0
12/05/2026
BR Adjuvant - TAMoxifen and goserelin Id: 506901000210101 Published date: Version: 1.0.0
506901000210101
1.0.0
12/05/2026
BR Adjuvant - TCH [DOCEtaxel, cARBOplatin and trastuzumab] Id: 58741000210107 Published date: Version: 3.0.0
58741000210107
3.0.0
06/08/2024
BR Adjuvant - TCy [DOCEtaxel and CYCLOPHOSPHamide] Id: 58711000210106 Published date: Version: 2.0.0
58711000210106
2.0.0
06/08/2024
BR Adjuvant - TCy and trastuzumab [DOCEtaxel, CYCLOPHOSPHamide and trastuzumab] Id: 58831000210109 Published date: Version: 2.0.0
58831000210109
2.0.0
06/08/2024
BR Adjuvant - zoledronic acid Id: 58761000210108 Published date: Version: 2.0.0
58761000210108
2.0.0
03/04/2025
BR Neoadjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W followed by DOCEtaxel Q3W Id: 58661000210104 Published date: Version: 4.0.0
58661000210104
4.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] dose dense Id: 57761000210107 Published date: Version: 2.0.0
57761000210107
2.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W Id: 57841000210100 Published date: Version: 3.0.0
57841000210100
3.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W followed by PACLItaxel Q1W Id: 59161000210100 Published date: Version: 4.0.0
59161000210100
4.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - cARBOplatin [5 AUC] Q3W and PACLItaxel Q1W followed by AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W with pembrolizumab Q3W Id: 393431000210109 Published date: Version: 1.0.0
Components ▾
cARBOplatin [5 AUC] Q3W, PACLItaxel Q1W with pembrolizumab Q3W Id: 393441000210101 Published date: Version: 0.0.13
AC [DOXOrubicin and CYCLOPHOSPHamide] with pembrolizumab Q3W Id: 393451000210103 Published date: Version: 0.0.6
Adjuvant pembrolizumab Q3W Id: 393461000210100 Published date: Version: 0.0.3
393431000210109
1.0.0
26/08/2024
BR Neoadjuvant/Adjuvant - D100-FEC [DOCEtaxel followed by fluorouracil, epirubicin and CYCLOPHOSPHamide] Id: 264191000210106 Published date: Version: 3.0.0
264191000210106
3.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - D75-FEC [DOCEtaxel followed by fluorouracil, epirubicin and CYCLOPHOSPHamide] Id: 264171000210107 Published date: Version: 3.0.0
264171000210107
3.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - FEC-D100 [fluorouracil, epirubicin and CYCLOPHOSPHamide followed by DOCEtaxel] Id: 58781000210100 Published date: Version: 5.0.0
58781000210100
5.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - FEC-D75 [fluorouracil, epirubicin and CYCLOPHOSPHamide followed by DOCEtaxel] Id: 59141000210101 Published date: Version: 5.0.0
59141000210101
5.0.0
24/08/2026
BR Neoadjuvant/Adjuvant - PACLItaxel Q1W Id: 58731000210104 Published date: Version: 3.0.0
58731000210104
3.0.0
12/06/2025
BR Neoadjuvant/Adjuvant - trastuzumab Q3W Id: 58821000210107 Published date: Version: 1.0.0
58821000210107
1.0.0
19/08/2024
BR Neoadjuvant/Adjuvant - trastuzumab subcutaneous Id: 58811000210102 Published date: Version: 1.0.0
58811000210102
1.0.0
19/08/2024
BR Neoadjuvant - CARBOplatin, PACLItaxel, pERTUZumab and trastuzumab Id: 506391000210108 Published date: Version: 1.0.0
506391000210108
1.0.0
04/05/2025
BR Neoadjuvant - cARBOplatin Q1W and PACLItaxel Q1W Id: 392951000210104 Published date: Version: 1.0.0
392951000210104
1.0.0
24/07/2024
BR Neoadjuvant - cARBOplatin Q3W and PACLItaxel Q1W followed by AC [DOXOrubicin and CYCLOPHOSPHamide] dose dense Id: 59821000210100 Published date: Version: 2.0.0
59821000210100
2.0.0
24/08/2026
BR Neoadjuvant - cARBOplatin Q3W and PACLItaxel Q1W followed by AC [DOXOrubicin and CYCLOPHOSPHamide] Q3W Id: 264181000210109 Published date: Version: 3.0.0
264181000210109
3.0.0
24/08/2026
BR Neoadjuvant - DOCEtaxel and trastuzumab followed by FEC [fluorouracil, epirubicin and CYCLOPHOSPHamide] followed by trastuzumab Id: 393021000210102 Published date: Version: 1.0.0
Components ▾
DOCEtaxel and trastuzumab Id: 393031000210100 Published date: Version: 0.0.9
FEC [fluorouracil, epirubicin and CYCLOPHOSPHamide] Id: 393041000210108 Published date: Version: 0.0.6
Adjuvant trastuzumab Id: 393051000210106 Published date: Version: 0.0.5
393021000210102
1.0.0
24/07/2024
BR Neoadjuvant - DOCEtaxel, pERTUZumab and trastuzumab Id: 59841000210106 Published date: Version: 2.0.0
59841000210106
2.0.0
06/08/2024
BR Neoadjuvant - PACLItaxel Q1W, pERTUZumab and trastuzumab Q3W Id: 57851000210102 Published date: Version: 3.0.0
57851000210102
3.0.0
23/05/2025
Discontinued Regimens Sort regimens by
BR NON-Metastatic - cARBOplatin Q3W and PACLItaxel Q1W Id: 58691000210109 Published date: Version: 1.2.2
58691000210109
1.2.2
20/08/2025